Search results
Diabetes management made easier: Your guide to a healthier lifestyle
The Economic Times· 5 hours agoWith advancements in our understanding of diabetes, both doctorsand patients are changing how they...
The role of technology in revolutionising stroke care is truly remarkable: Dr Sharath Kumar - ET...
The Economic Times· 6 hours agoWhat are the major factors contributing to the 20 per cent increase in stroke cases among young...
CKD market to grow at CAGR of 19.6% from $2.2b in 2023 to $13.5b in 2033 - ET HealthWorld
The Economic Times· 6 hours agoGlobalData’s latest report 'Chronic Kidney Disease: Seven-Market Drug Forecast and Market Analysis',...
Women with a common hormonal disorder have few good treatment options. Could GLP-1 drugs help?
BioPharma Dive· 6 hours agoObesity drugs like Wegovy are proving useful in many other diseases. Polycystic ovary syndrome, a...
Quince Therapeutics doses first subject in Ataxia-Telangiectasia trial
Clinical Trials Arena· 6 hours ago“There are currently no approved therapeutic treatments in any global market for this rare...
Amber Therapeutics device reduces seizures by 80% in first UK trial
Medical Device Network· 7 hours agoIt’s not just epilepsy that can be targeted by DBS devices. Earlier this week...Software, designed...
Amber Therapeutics device reduces seizures by 80% in first UK trial
Clinical Trials Arena· 7 hours agoIt’s not just epilepsy that can be targeted by DBS devices. Earlier this week...Software, designed...
Sanofi reports data from Phase II demyelinating polyneuropathy trial
Clinical Trials Arena· 8 hours agoParticipants received the treatment for 24 weeks in the part A portion, followed by an optional ...
Chronic kidney disease market to grow at 19.6 percent CAGR in seven major markets during 2023-33:...
Financial Express· 8 hours agoGlobalData’s latest report “Chronic Kidney Disease: Seven-Market Drug Forecast and Market Analysis,”...
First-of-its-kind Intellia data suggest CRISPR drug could be given more than once
BioPharma Dive· 8 hours agoThe findings provide early proof that multiple doses of a gene editing medicine can be safely...